Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jan 25 | RNAC Cartesian Therapeutics | Common Stock | Sell | Dispose S | No | No | 16.8322 | 8,708 | 146.57 k | 204,096 |
3 Jan 25 | RNAC Cartesian Therapeutics | Common Stock | Sell | Dispose S | No | No | 16.7219 | 8,563 | 143.19 k | 212,804 |
2 Jan 25 | RNAC Cartesian Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 57,500 | 0.00 | 221,367 |
2 Jan 25 | RNAC Cartesian Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 16.93 | 169,100 | 2.86 mm | 169,100 |
2 Jan 24 | RNAC Cartesian Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 4,654,100 | 0.00 | 4,916,056 |
2 Jan 24 | RNAC Cartesian Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.6552 | 5,971,000 | 3.91 mm | 5,971,000 |
13 Nov 23 | RNAC Cartesian Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 2.06 | 282,800 | 582.57 k | 261,956 |
13 Nov 23 | RNAC Cartesian Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 2.06 | 169,725 | 349.63 k | 544,756 |
13 Nov 23 | RNAC Cartesian Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 2.06 | 13,600 | 28.02 k | 714,481 |
13 Nov 23 | RNAC Cartesian Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 2.06 | 55,000 | 113.30 k | 728,081 |